Main Menu
Main Menu
Menu

Funding Opportunity: Genomic Monitoring of Pathogens in Water – C3 Hub Webinar Registration

by

Community Coordination and Collaboration Hub (C3 Hub) Funding Opportunity

Ontario Genomics and Genome Canada invite you to an introductory information session about a new funding opportunity, the Community Coordination and Collaboration Hub (C3 Hub), within our recently launched targeted genomic initiative known as .

The Community Coordination and Collaboration Hub (C3 Hub) will be a single Pan-Canadian team responsible for connecting regional surveillance projects and ensuring that data from monitoring antimicrobial resistance (AMR) and emerging pathogens (EPs) are used to inform public policy decisions. We encourage you to attend our info session to learn more about the GeMPaW strategic initiative, and more specifically, the C3 Hub.

Date: June 1, 2023
Time: 12:30-1:30 pm ET
Location: Virtual (Zoom) – Link will follow registration

Register today! Participants interested in attending the info session must first register using the C3 Hub Individual Participation Registration form to receive the Zoom link via email. The deadline for individual registration is May 30, 2023. Registration is now open—please don’t delay.

If you have any questions about this info session or the GeMPaW initiative, please contact Laura Riley, Director, Sector Innovation & Programs, Ontario Genomics at lriley@ontariogenomics.ca.

Ontario Genomics investments drive cutting-edge R&D in health, environmental sustainability and agricultural resilience

by

Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced federal support through Genome Canada for three late-stage Ontario Genomics research and development projects tackling major challenges in health, environment and agriculture through genomics.

The Government of Canada, in collaboration with the provincial government, industry and healthcare organizations, as well as other partners, is investing a total of over $16.3 million into Ontario projects out of the $56.7 million funding announced for projects across Canada.

Genomics research is driving innovations and delivering solutions to global challenges like climate change, public health and food security. Ontario\’s robust research ecosystem has developed world-class strength in genomics with major investments over more than 23 years to solidify our position as a world leader in the field.

“Genomics is a key technology that is instrumental in responding to national and global challenges. Projects like the ones announced under the Genome Canada’s Genomics Applications Partnership Program are central to make sure the Canadian research system grow and remain at the forefront globally, leading to more cutting-edge genomics science that delivers real impacts for the health and economic growth of Canadians.”

– The Honourable François-Philippe Champagne,
Minister of Innovation, Science and Industry.

The projects announced today will harness cutting-edge genomics science to deliver real-world impacts for healthier, more sustainable and prosperous communities across Ontario. The GAPP program leverages world-leading expertise to accelerate the translation of scientific knowledge into broad economic and societal benefits for Ontario, such as job creation and revenue generation.

“Enabling impact-focused research partnerships between academia, industry, public sector institutions and other partners is a powerful vehicle for generating long-term growth, low-carbon productivity and a healthier future for Canadians. Genome Canada is proud to mark the 10th anniversary of the Genomics Application Partnership Program (GAPP) and invest in our 100th GAPP with the vital support of the Government of Canada.”

– Dr. Rob Annan,
President and CEO, Genome Canada

Ontario Genomics plays a vital role in advancing these projects by supporting the development of their proposals, helping them access diverse funding sources, and finding the right industry partners to take this research out of the lab to apply it to the world’s most pressing challenges. Since its inception in 2000, Ontario Genomics has raised more than $1.27 billion for genomics applied research in Ontario and directly supported more than 9,100 trainees and jobs. We have 110+ active projects, 500+ impactful partnerships and have secured $1.34 billion in follow-on investments.

“Partnerships between the researchers and industry are the cornerstone of Ontario’s thriving innovation community. By supporting the development and uptake of new technologies that provide game-changing solutions to the world’s most pressing challenges, Ontario Genomics is helping to nurture healthy people, a healthy economy, and a healthy planet for generations to come.”

– Dr. Bettina Hamelin,
President and CEO, Ontario Genomics.

This investment will support researchers at the Western University, University of Toronto, and Ontario Institute for Cancer Research. In collaboration with industry partners, including Greenlight Biosciences, Inc., Ontario Greenhouse Vegetable Growers, Metso-Outotec, and Canadian Partnership for Tomorrow’s Health, these genomics-based projects will have real, positive impacts on our healthcare system, as well as the environment.

Marking a decade of impact-focused research investment
The projects announced today are funded through GAPP. Marking its 10th anniversary this year, and its 100th funded project, GAPP leverages world-leading expertise and diversified partnerships to accelerate translation of scientific knowledge into broad economic and societal benefits for Ontario and Canada.

  • Biopesticide with new modes of action for control of highly polyphagous mite agricultural pests
    Receptors: Greenlight Biosciences, Inc. and Ontario Greenhouse Vegetable Growers
    This project will develop, register and commercialize RNAi biomiticide (biopesticides specific for mites) against the two-spotted spider mite to effectively manage its outbreaks. This novel biopesticide will not only provide the sector with potential economic benefits of ~$600 million per year, but it will also provide growers with an alternative to synthetic chemical insecticides, thus reducing their environmental footprint.
  • Developing novel bioleaching process for Ni recovery from pyrrhotite streams
    Receptor: Metso-Outotec
    This project will use genomics and bioleaching technologies to characterize and engineer microbial populations to treat pyrrhotite tailings, waste streams of current mining practices, for nickel extraction. The extraction of nickel from pyrrhotite tailings in Canada has a potential value of $26 billion, can provide a source of critical minerals for production of electric vehicle batteries, and enable significant (>75%) reduction in waste generation from mining processes.
  • Enabling personalized genomics in health with the CanPath data safe haven
    Receptor: Canadian Partnership for Tomorrow’s Health
    This project will build upon CanPath’s existing infrastructure to democratize access to the platform, developing a secure environment within which researchers, clinicians and industry in Canada can access deeply characterized population health and biobank data. It will support the development of Canada’s biotechnology sector and industry research as well as creating the ability to harmonize with other national precision medicine programs. The ultimate result will be earlier diagnosis of disease and medical interventions for Canadians.

Funding Opportunity: Announcing the launch of BioCreate Cohort 2

by

Ontario Genomics’ (Cohort 2) is open to small- and medium-sized enterprises (SMEs) in southern Ontario seeking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture, and cleantech sectors at a Technology Readiness Level (TRL) of 4+.

BioCreate provides funding, access to mentorship and business support to help companies bring new products and technologies to market.

Program Highlights:

  • The multi-phase BioCreate program includes direct, non-repayable funding of $150,000 that will be matched by an additional $100,000 (minimum) from participating companies to a total project size of $250,000 or more.
  • Funded companies will have access to 18 months of intensive business mentorship and access to critical infrastructure provided by Ontario Genomics’ strategic sectoral and regional partnerships.
  • Each cohort will conclude with an investor showcase, giving the companies an opportunity to pitch to investors and potential partners.

The BioCreate Program will consist of three phases:

Application Steps and Dates

Interested SMEs should submit the initial BioCreate intake form at any time. Following the submission of this form, a representative from the BioCreate team will reach out to discuss your project idea. Eligible applicants will be invited to submit an application.

Interested SMEs should review the Program Guide for more information on the BioCreate program, including eligibility requirements and evaluation criteria.

If you have questions, please contact BioCreate@ontariogenomics.ca.

The deadline to submit an intake form to be considered for Cohort 2 is June 30, 2023. Additional details related to BioCreate and the application process can be .

Complete the intake form now to find out more about your company’s eligibility!

The BioCreate program is supported by the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and Ontario Genomics. The current budget is greater than $7 million over five years.

Ontario Genomics & CANSSI Ontario Announce $200K for Postdoctoral Fellowships in Genome Data Science

by

TORONTO, ON. — Ontario Genomics and CANSSI Ontario have awarded two fellowships of $200,000 total for early-career scientists to pursue work in the areas of statistical genetics, environmental genetics, or the economics and impacts of genomic technologies, in a climate-changing world.

The Ontario Genomics-CANSSI Ontario Postdoctoral Fellowship in Genomic Data Science, originally conceived as a single fellowship in 2021, has since evolved into two awards in 2023.

2023 recipients of Postdoctoral Fellowships in Genome Data Science

The Fellowship offers two-year salary support for up to $50,000 per year. We are delighted to congratulate the recipients of this Fellowship:

1. Dr. Ander Díaz-Navarro, Department of Molecular Genetics, University Toronto
Supervisors: Drs. Lincoln Stein and Bo Wang (University of Toronto)
Project: In Silico Generation of Synthetic Cancer Genomes Using Deep Learning Algorithms

2. Dr. João Pedro Fontenelle, Institute of Forestry and Conservation, Daniels Faculty of Forestry, University of Toronto
Supervisors: Drs. Patrick James (University of Toronto) and Catherine Cullingham (Carleton University)
Project: The Influence of Cyclic Population Outbreaks on Population Genetic Structure Inferences

Drs. Díaz-Navarro and Fontenelle, are profiled, along with information about their background, research, and proposed research projects, here: Díaz-Navarro | Fontenelle

Ontario Genomics is proud to be a partner with CANSSI Ontario to help build research capacity in data science and genomics in Ontario.

About

The Ontario Genomics-CANSSI Ontario Postdoctoral Fellowship in Genome Data Science was created to support research projects that deepen our understanding of genomic epidemiology of infectious disease, using genomics for pathogen surveillance or host-virus genetic interaction by providing salary support for up to two years for an early career investigator pursuing research in the areas of statistical genetics or genetic epidemiology.

About Ontario Genomics:
Established in 2000, Ontario Genomics is a not-for-profit organization leading the application of genomics-based solutions to drive economic growth, improved quality of life, and global leadership for Ontario. As part of its strategic vision, Ontario Genomics (OG) is dedicated to supporting the development of educational resources that demonstrate how genomics plays a vital role to address key challenges in our society. Ontario Genomics also plays a role in advancing genomics projects and programs across the province by supporting the development of proposals, helping researchers access diverse funding sources, and finding the right industry partners to take this research out of the lab to apply it to the world’s most pressing challenges. Since its inception, Ontario Genomics has raised more than $1.27 billion for genomics applied research in Ontario and directly supported more than 9,100 trainees and jobs. OG supports 110+ active projects, 500+ impactful partnerships and has secured $1.34 billion in follow-on investments.

About CANNSI Ontario:
CANSSI Ontario is the Ontario Regional Centre of the Canadian Statistical Sciences Institute (CANSSI). Its goal is to strengthen and enhance research and training in data science by developing programs that promote interdisciplinary research and enable multidisciplinary collaborations.

It\’s Not Magic, It\’s Genomics – Ontario Genomics Annual Report 2021-2022

by

Ontario Genomics is pleased to launch our 2021-22 Annual Report

The theme of this year’s annual report, “It’s Not Magic, It’s Genomics”, captures the essence of what is truly possible in this revolutionary, cutting-edge space. Although sometimes it may seem like magic, genomics offers scientifically sound and proven solutions to some of humanity’s biggest challenges: climate change, food insecurity, and acute and chronic disease.

This year, our advancements in agriculture and food have been a particular source of pride for Ontario Genomics. Expanding on our 2020 white paper: Engineering Biology – A platform technology to fuel multi-sector economic recovery and modernize biomanufacturing in Canada, we examined Canada’s opportunity in food innovation and food export. In 2021 we released a first-of-its-kind Canadian report that examines the growing global demand for diversified food production while complementing traditional agricultural approaches, thereby creating up to $12.5B per year in new economic opportunity for Canada.

Ontario Genomics’ multi-sector vision of healthy people, a healthy economy, and a healthy planet through genomics innovations depends on Ontario’s greatest strength to make it all happen: our talent. This year’s annual report features a special overview of our work to prepare the greater public and our future workforce for the transdisciplinary and entrepreneurial jobs of today and tomorrow.

And we are only just getting started. With the power of genomics, we can take the seemingly magical and make it the foundation of Ontario’s economic strength and prosperity for generations to come.

Report – Clean DNA: How Genomics Can Reduce Emissions and Drive Economic Growth for Canada

by

The climate crisis demands innovation and new strategies. Scientists are finding potential solutions from an unexpected place: biology. The mapping of the human genome led to breakthroughs in medicine, but gene mapping can apply to many other fields, including agriculture, food, resource extraction and manufacturing.

It’s now possible to harness natural micro-organisms such as bacteria, yeast and micro-algae to manufacture many of the world’s physical materials, potentially with improved performance and fewer emissions. Bacteria is engineered to make proteins. Meat and fish cells are cultivated for burgers, nuggets or sushi. Sugar-based substances can replace petroleum in nylon. Researchers are developing ways to use microbes to devour toxins and bacteria to consume methane.

A recent McKinsey Global Institute report found that 60 percent of physical inputs to the global economy could, in principle, be produced biologically — with an economic value of at least U.S. $2 trillion between 2030 and 2040. This would represent a turn toward more biology-based processes, away from petroleum-based synthetic chemistry, says Bettina Hamelin, president and CEO of Ontario Genomics.

Hamelin notes that nature has made chemicals and proteins for billions of years. Science can reproduce those processes to make products we want and need. “We are building on what is happening in nature,” she says. “Biology, and biotechnology, is the only way toward a sustainable and prosperous future.”

Canada is a world leader in genomics, engineering, chemistry, mathematics, big data, AI and biotechnology. We have all the ingredients for a successful industry, but we risk falling behind other jurisdictions that benefit from significant public and private investment in the sector.

Moving swiftly to a low-carbon society will require enormous effort by governments, businesses and individuals. That should include measures that allow Canadian startups in genomics and biological engineering to scale up their technologies, from public-private partnerships and talent development, to community engagement and building product trust.

Save the Date for Canada SynBio Conference (June 13-15, 2023)

by

Ontario Genomics is pleased to announce that our annual Canada SynBio Conference is back for a special fifth-anniversary edition!
Save the Date: June 13-15, 2023

The brings together researchers, industry, government and students to showcase the successes and opportunities of engineering biology in Canada and the world. (Sign Up for Updates)

Canada is at the next frontier of innovation through engineering biology. As the global bio-revolution accelerates around us and Canada embarks on a Canadian genomics strategy, our goal is to continue to foster the connections, networks and communities that will advance a common vision and Canada’s position as a leader in engineering biology.
This conference plays a pivotal role in catalyzing new partnerships, technological development, and attracting investment from multiple sources.

This is a one-of-a-kind conference that brings together national and international leaders in the field of engineering biology to foster inter-sector partnerships and contribute to establishing Canada as an international powerhouse in the bioeconomy.

The 2022 edition of Canada SynBio gathered over 350 national and international leaders and had a vast social media reach of over 272k. Learn more about previous SynBio Conferences.

Join us as we explore emerging themes in engineering biology through a series of engaging presentations, dynamic workshops and interactive networking events.

We look forward to working together to continue the momentum of Canadian engineering biology.

Save the date for the most engaging engineering biology conference you’ll attend all year!

Ontario Genomics Partners with The Cultivated B. to Drive Growth of Ontario’s Cellular Agriculture Industry

by

October 27, 2022, Burlington – The Cultivated B. announce an expansion in cellular agriculture operations to Canada, opening their 130,000-square-foot manufacturing facility and innovation hub in Burlington, Ontario, Canada. Ontario Genomics is partnering on the creation of this innovation hub to build on the momentum of this budding cellular agriculture ecosystem. The Cultivated B. (TCB) is a bioengineering company that provides access to plant-based and cell-based alternative protein sources and plans to hire over 200 employees at the new facility in the coming years. The facility will develop and produce bioreactors from 500 ml to 25,000 liters, photobioreactors and high-precision devices for cellular agriculture and precision fermentation. This will enable other businesses to produce alternative proteins at an industrial scale, whether in the cultivated meat, ingredients, pharmaceutical, or cosmetic industries. The facility will further house PreFer Industries, a subsidiary of The Cultivated B., focusing on developing alternative, particularly plant-based protein sources through precision fermentation.

Earlier this month at Toronto Global, TCB and Ontario Genomics signed a memorandum of understanding to drive forward a shared vision of developing the cellular agriculture ecosystem within Ontario and Canada, and offering opportunities to companies within the cellular agriculture and biotechnology industries. This strategic partnership will see approximately 20,000 square foot of the building dedicated to growing an innovation hub, providing small and mid-size cellular agriculture and other biotechnology companies with access to laboratory space, bioreactors and mentorship to test and scale up their products. Enabling access to this necessary and specialized infrastructure will help shape the landscape of the cellular agriculture industry within Canada and drive forward further growth.

“This facility in Canada is more than just a production site. Alongside the development and production of pioneering technology and bioreactors, we want to help other enterprises in the cellular agriculture and pharmaceutical industry flourish,” says Hamid R. Noori, Co-Founder and Co-CEO of The Cultivated B. “Our innovation hub, in particular, will help shape the landscape for cellular agriculture in the country and fill a major gap that we saw. We have aligned our goals with the government and Ontario Genomics, and I look forward to seeing how we will drive forward innovation and economic development together.”

“Canada, and specifically Ontario, has an opportunity to be at the forefront of a transformative industry. Our partnership with TCB will support biotechnology startups as they scale up their capacity to produce much needed foods, ingredients and materials,” says Bettina Hamelin, President and CEO, at Ontario Genomics. “There is undeniable growing consumer demand and huge industry momentum for these new and innovative products. This partnership is a critical next step for Canada to act on a window of opportunity to enhance resiliency in food supply chains while meeting common food security and sustainability goals.”

“Cells are essentially machines, and we are redesigning cells and plants to have them operate in the exact way we desire. Our new facility in Canada is a massive leap forward and a driving force behind this next industrial revolution,” says Raphael Heiner, Co-Founder and Co-CEO of The Cultivated B. “We are striving to use natural resources more efficiently, and our innovation hub will support other businesses working toward the same goal.”

Since 2019, Ontario Genomics has been driving the growth of the cellular agriculture community in Ontario and Canada. In November 2021, Ontario Genomics released the report Cellular Agriculture – Canada\’s $12.5 Billion Opportunity in Food Innovation, featuring extensive stakeholder input and economic analysis. The report found that the cellular agriculture industry is rapidly evolving and suggests a Canadian economic opportunity as high as $12.5 billion per year with the creation of up to 142,000 jobs. To achieve this, the country must develop a national vision and strategy for the Canadian cellular agriculture industry in the near term, establish a clear and transparent regulatory framework for cellular agriculture products in Canada, and provide supporting mechanisms for research and commercial development.

Following the report, in May 2022, Ontario Genomics and the Canadian Food Innovation Network (CFIN) announced more than $900K in funding for four cutting-edge cellular agriculture-focused food and beverage projects through their AcCELLerate-ON competition. AcCELLerate-ON is Canada’s first cellular agriculture-focused competition supporting the research and development of novel and innovative viable food production methods with the intent to drive economic growth and Ontario’s global leadership in this new and sustainable way to produce food. Ontario Genomics recently announced their new BioCreate program open to small- and medium-sized enterprises (SMEs) in southern Ontario seeking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture and cleantech sectors. Today’s announcement presents the next step to drive Ontario’s leadership in the cellular agriculture space, while creating the jobs, driving economic growth and the sustainable production of food and food ingredients for Ontario, and beyond.

-30-

Media Contact:
Polina Martins
Director of Communications and Public Affairs
Pmartins@ontariogenomics.ca

Read The Cultivated B. news release.
Read the Toronto Global news release.

About The Cultivated B.
The Cultivated B. (TCB) is breaking new ground in the development of advanced biotechnology and bioengineering to enhance access to plant and cell-based alternative protein sources. TCB’s growing multinational team of scientists uses cellular agriculture, precision fermentation, and new approaches in bioreactor technology to drive forward the cultivated meat, food production, and personal care industries. By providing pioneering technology, TCB enriches the alternative protein and agritech industries and enables other companies to produce alternative proteins at an industrial scale. By utilizing TCB’s research and development capabilities, the parent company, InFamily Foods, will transform into a fully integrated food producer focusing on technology, innovation, and sustainable production serving future generations. With a fundamental commitment to minimizing the natural resources used, TCB is paving the way to a sustainable future locally, regionally, and globally.

About Ontario Genomics
Ontario Genomics is a not-for-profit organization funded by the Ontario government and Genome Canada and leading the application of genomics-based solutions to drive economic growth, improved quality of life and global leadership for Ontario. Ontario Genomics plays a vital role in advancing projects and programs by supporting the development of their proposals, helping them access diverse funding sources, and finding the right industry partners to take this research out of the lab to apply it to the world’s most pressing challenges. Since its inception in 2000, Ontario Genomics has raised more than $1.27 billion for genomics applied research in Ontario and directly supported more than 9,100 trainees and jobs. We have 110+ active projects, 500+ impactful partnerships and have secured $1.34 billion in follow-on investments.

About Toronto Global
Toronto Global’s team of experienced business advisors works to help international companies access the most dynamic and innovative region in the world. We actively seek global companies interested in expanding to the Toronto Region and connect investors with the right opportunities that will facilitate the successful growth of their business.
As an arms-length organization representing the Cities of Mississauga, Brampton and Toronto, and the Regional Municipalities of Durham, York, and Halton, we work with our partners in the Ontario and Canadian governments to provide a comprehensive, customized service that allows for a smooth transition for international companies wishing to do business here. Toronto Global is dedicated to understanding our clients’ business needs and delivering tailored, innovative solutions that will set the stage for their success in the Toronto Region.

Ontario Genomics and Government of Canada Announce BioCreate Program

by

Government of Canada invests over $5.6 million to help early-stage genomics companies bring new products to market

FedDev Ontario investment to support over 30 companies, create and maintain 160 jobs, and develop eight new products, services or processes, and over 32 new patents

WATCH THE ANNOUNCEMENT

October 21, 2022 – Toronto, Ontario – Federal Economic Development Agency for Southern Ontario (FedDev Ontario)

Research in genomics and engineering biology has led to the development of cutting-edge technologies and innovations in a number of important sectors, including public health, food, and the environment. By examining the genetic and environmental factors impacting the health of Canadians and understanding environmental changes, we can develop technologies and tools to address world challenges like disease and climate change, as well as to improve the health and well-being of Canadians.

Today, the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), announced an investment of over $5.6 million for Ontario Genomics to deliver the . The program will provide seed funding and support to help genomics SMEs in the health, food and agriculture, and cleantech sectors to bring new products and technologies to market.

Southern Ontario is recognized as a world leader in genomics and engineering biology research, but innovators often encounter challenges that prevent promising start-ups from scaling up and moving from research to commercialization. Through the BioCreate program, Ontario Genomics, in partnership with Velocity (Waterloo), McMaster Innovation Park/Synapse Life Sciences Consortium (Hamilton), Toronto Metropolitan University Science Discovery Zone (Toronto), and Cleantech Commons (Peterborough), will provide over 30 successful applicants with access to critical infrastructure including lab space, business support tools, mentoring, and tech development guidance.

Participating businesses are expected to create and maintain up to 160 highly skilled jobs, as well as create eight new products, services, or processes and more than 30 new patents. As well, approximately 25 percent of the firms participating in the program will be directed to an investment fund (The Firehood) that focuses on connecting women founders with mentors, partners and/or customers to help develop their business.

The Government of Canada is committed to supporting innovation in this important sector to help SMEs grow and commercialize technologies and improve the well-being of Canadians, create quality jobs, and boost Canada’s economy.

Quotes

“Supporting Canadian innovators is a priority for the Government of Canada and today’s investment in Ontario Genomics and the BioCreate Program will provide Canadian genomics companies within the health, food and agriculture and cleantech sectors with access to the tools, mentorship and lab space they need for growth and success. This program will create 160 highly skilled jobs across Southern Ontario and help secure Canada’s place as a global leader in research and innovation.”
– The Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario

“Ontario Genomics is helping to further develop a network in leading-edge innovation. This project will support the development of a healthy pipeline of high-potential start-up companies in health, agri-food and cleantech sectors, and create and maintain up to 160 highly skilled jobs across southern Ontario.”
– Bettina Hamelin, President and CEO Ontario Genomics

Quick Facts

  • Genomics is the study of all the genetic information of an organism’s genes.
  • Engineering (or synthetic) biology is a convergence of genomics and molecular biosciences with computing, automation, miniaturization, artificial intelligence (AI), and the application of engineering principles to biological systems.
  • Established in 2000, Ontario Genomics is a Toronto-based not-for-profit organization leading the application of genomics-based solutions across key sectors of the economy to drive economic growth, improved quality of life, and global leadership for Ontario.
  • Ontario Genomics has raised more than $1.27 billion for genomics research in Ontario and directly supported more than 9,100 jobs since 2000.
  • In 2021, the Government of Canada announced the development of at $400-million Pan-Canadian Genomics Strategy.
  • The Regional Innovation Ecosystem initiative, delivered by FedDev Ontario, aims to create, grow, and develop strong and inclusive regional ecosystems that support business growth and innovation, as well as the entrepreneurial environment necessary to foster more innovative regional economies and increase the competitiveness of SMEs.
  • Since November 2015, and throughout the pandemic, FedDev Ontario has invested more than $2.2 billion to support over 3,000 projects across southern Ontario, helping to create or maintain more than 180,000 jobs, and leveraging over $3.1 billion in additional investment in the region.

Associated Links

FedDev Ontario
Ontario Genomics

Contacts

Edward Hutchinson
Press Secretary, Office of the Minister responsible for the Federal Economic Development Agency for Southern Ontario
Edward.Hutchinson@feddevontario.gc.ca

FedDev Ontario Media Relations
feddevontariomediarelations-relationsmedias@feddevontario.gc.ca

Polina Martins
Director of Communications and Public Affairs, Ontario Genomics
pmartins@ontariogenomics.ca